glucagonoma syndrome

glu·ca·gon·o·ma syn·drome

necrolytic migratory erythema or intertriginous and periorofacial dermatitis, stomatitis, anemia, weight loss, and hyperglycemia resulting from glucagon-secreting pancreatic islet cell tumors.

glucagonoma syndrome

A symptom complex associated with glucagonoma, a tumor of post-menopausal ♀ who often have DM, blistering dermatitis–necrolytic migratory erythema, epidermal necrosis, subcorneal pustules, suppurative folliculitis, confluent parakeratosis, epidermal hyperplasia, and prominent papillary dermal hyperplasia, weight loss, normochromic anemia, ileus, constipation or diarrhea, glossitis, angular cheilitis, venous thrombosis, hypoproteinemia, neuropsychiatric changes

glu·ca·gon·o·ma syn·drome

(glūkă-gon-ōmă sindrōm)
Necrolytic migratory erythema or intertriginous and periorofacial dermatitis, due to glucagon-secreting pancreatic islet cell tumors.
References in periodicals archive ?
The patient which has been described in this paper had a glucagonoma syndrome with mild diabetes.
Case of the Season: Glucagonoma Syndrome. Semin Roentgenol 2005 Jan;40(1):4-7
with hallmarks of the glucagonoma syndrome. The classic features
such as in the glucagonoma syndrome, when these peptide hormones may be
Other cutaneous manifestations of glucagonoma syndrome include angular cheilitis and painful glossitis.
The glucagonoma syndrome and necrolytic migratory erythema: a clinical review".
Differential diagnosis includes epidermolysis bullosa, cystic fibrosis, glucagonoma syndrome, widespread candidiasis, pellagra, seborrheic dermatitis, hypovitaminoses, atopic dermatitis, celiac disease, and congenital periorificial and palmo-plantar keratoderma (3).
The glucagonoma syndrome: a review of its features and discussion of new perspectives.
The glucagonoma syndrome. Clinical features, diagnosis, and treatment.
Her diagnosis was glucagonoma syndrome, a rare [alpha]-cell tumor of the pancreas; there are only about 400 reported cases.
[1] discovered the origin of this disorder thanks to radioimmunoassay technique for glucagon and named this combination of symptoms as a glucagonoma syndrome [2].
* Glucagonoma Syndrome. This syndrome, specific for certain pancreatic tumors, is usually misdiagnosed until the rumors have metastasized.